ClinicalTrials.Veeva

Menu

Physical Activity in Persons With Parkinson's Disease (ActivPARK)

Karolinska Institute logo

Karolinska Institute

Status

Enrolling

Conditions

Physical Inactivity
Parkinson Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06901869
2024-06332 (Other Grant/Funding Number)
2024-07526-01

Details and patient eligibility

About

Parkinson's disease (PD) is a leading neurodegenerative health condition in Sweden and a public health concern. Although no cure exists, functional independence and participation in society remain top priorities, and can be achieved through targeted physical activity (PA) interventions. To date, few longitudinal cohort studies have been conducted, using PA as main outcome in therapy research, partly due to the complex nature of predicting and controlling this phenomenon. To help address this knowledge gap, the overall purpose of the future long-term (ActivPARK) study is to enhance knowledge of the evolution of PA behavior, and how it is influenced beyond the disease characteristics using a broad explanatory model, in persons with PD from a diversity of settings in Sweden with the aim of prescribing tailored and personalized interventions to enhance functioning, health, and wellbeing throughout the disease progression and recommend potential health care pathway modifications.

The investigators have just established an expert group, comprising researchers, healthcare professionals, and PD organisations (including persons with PD) and reached consensus on essential priority clinical therapy research questions on PA and methodological considerations. The next phase entails performing a multicentre feasibility/pilot study, further developing and refining the assessment battery and research questions linked to the improved explanatory model for PA and methodology, to inform the definite larger clinical cohort study.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with Parkinson's disease
  • Mild to severe disease severity ( Hoehn & Yahr 1-4).

Exclusion criteria

  • None

Trial design

50 participants in 1 patient group

People with Parkinson's disease
Description:
No intervention

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Erika Franzén; Compliance Office Karolinska Insitutet

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems